BOLT vs TT · rev $7.7M vs P/E 36, rev $21.32B
Bolt Biotherapeutics (BOLT) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
BOLT currently screens at market cap $11.3M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the BOLT and TT stock pages for the full models.
Not investment advice.